Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Research into IBD; development of common data elements for IBD research; establishment of NIH Office of Autoimmune Research.; Step therapy protocols including the Safe Step Act (S. 652 and H.R. 2630); Pharmacy Benefit Manager (PBM) legislation including S. 1339; the Pharmacy Benefit Manager Reform Act.
Pharmacy Benefit Manager Reform Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Research into IBD; development of common data elements for IBD research; establishment of NIH Office of Autoimmune Research.; Step therapy protocols including the Safe Step Act (S. 652 and H.R. 2630); Pharmacy Benefit Manager (PBM) legislation including S. 1339; the Pharmacy Benefit Manager Reform Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · 2A
FY 2024 report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Source: Senate LDA
Research into IBD; development of common data elements for IBD research; establishment of NIH Office of Autoimmune Research.; Step therapy protocols including the Safe Step Act (S. 652 and H.R. 2630); Pharmacy Benefit Manager (PBM) legislation including S. 1339; the Pharmacy Benefit Manager Reform Act.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Consolidated Appropriations Act, 2022
Client: USAGAINSTALZHEIMER'S · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Report language and accelerated approval provisions in H.R. 2471 - Consolidated Appropriations Act of 2022.
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 6000 - Cures 2.0 Act, Sec. 501; H.R. 5585 - Advanced Research Project Agency-Health Act.
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 6000 - Cures 2.0 Act, Sec. 501; H.R. 5585 - Advanced Research Project Agency-Health Act.
Food and Drug Amendments of 2022
Client: USAGAINSTALZHEIMER'S · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Food and Drug Amendments of 2022
Client: USAGAINSTALZHEIMER'S · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 464, H.R. 2163 - the Safe Step Act.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 464 and H.R. 2163, the Safe Step Act.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
H.R. 6000 - Cures 2.0 Act; H.R. 5585 - Advanced Research Project Agency-Health Act.
H.R. 6000 - Cures 2.0 Act; H.R. 5585 - Advanced Research Project Agency-Health Act.
S. 464, H.R. 2163 - the Safe Step Act.
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
S. 464 and H.R. 2163, the Safe Step Act.
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Safe Step Act
Client: NATIONAL PSORIASIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 2279, S. 2546 - Safe Step Act and issues related to step therapy. Membership in the Crohn's & Colitis Congressional Caucus.
Safe Step Act
Client: NATIONAL PSORIASIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Issues related to step therapy protocols; H.R. 2279, S.2546 - Safe Step Act
Safe Step Act
Client: NATIONAL PSORIASIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
Safe Step Act
Client: CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Issues related to step therapy protocols; H.R. 2279, S. 2546 - Safe Step Act. Congressional Crohn's & Colitis Caucus.
H.R. 2279, S. 2546 - Safe Step Act and issues related to step therapy. Membership in the Crohn's & Colitis Congressional Caucus.
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Issues related to step therapy protocols; H.R. 2279, S.2546 - Safe Step Act
Issues related to step therapy protocols; H.R. 2279, S. 2546 - Safe Step Act. Congressional Crohn's & Colitis Caucus.
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
FY 2024 report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Research into IBD; development of common data elements for IBD research; establishment of NIH Office of Autoimmune Research.; Step therapy protocols including the Safe Step Act (S. 652 and H.R. 2630); Pharmacy Benefit Manager (PBM) legislation including S. 1339; the Pharmacy Benefit Manager Reform Act.
FY 24 appropriations issues pertaining to Inflammatory Bowel Diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
FY 2024 report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
FY 24 appropriations issues pertaining to Inflammatory Bowel Diseases.
Research into IBD; development of common data elements for IBD research; establishment of NIH Office of Autoimmune Research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · fourth_quarter · Q4
Report language and accelerated approval provisions in H.R. 2471 - Consolidated Appropriations Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · fourth_quarter · Q4
FY 23 appropriations funding for Crohns disease and ulcerative colitis medical research and public health activities.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · third_quarter · Q3
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · third_quarter · Q3
FY 23 appropriations funding for Crohns disease and ulcerative colitis medical research and public health activities.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · second_quarter · Q2
FY 23 appropriations legislation and policies pertaining to psoriatic disease public health activities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · second_quarter · Q2
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 5585 - Advanced Research Project Agency-Health Act. Prescription Drug User Fee Act reauthorization bills: Food and Drug Amendments of 2022 (H.R. 7667) FDASLA Act of 2022 (S. 4348).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · second_quarter · Q2
FY 23 appropriations legislation and policies pertaining to Crohns & Colitis medical research, public health activities and therapy development activities.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · first_quarter · Q1
Authorizing bills for the Advanced Research Projects Agency - Health (ARPA-H); H.R. 6000 - Cures 2.0 Act, Sec. 501; H.R. 5585 - Advanced Research Project Agency-Health Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · first_quarter · Q1
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
FY 2022 appropriations focused on Inflammatory Bowel Disease (IBD) medical research, public health and therapy development issues; FY 2022 budget reconciliation; Resolution of FY 22 appropriations with a focus on Crohns and colitis medical research, public health and therapy development policies; FY 23 appropriations focused on Crohns and colitis medical research, public health and therapy development policies.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2022 · second_quarter · RA
FY 2023 funding for Chronic Disease Education and Awareness and programs focused on psoriasis and psoriatic arthritis.
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · fourth_quarter · Q4
FY 2022 appropriations focused on Inflammatory Bowel Disease (IBD) medical research, public health and therapy development issues; FY 2022 budget reconciliation.
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · fourth_quarter · Q4
H.R. 6000 - Cures 2.0 Act; H.R. 5585 - Advanced Research Project Agency-Health Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · third_quarter · Q3
FY 2022 appropriations focused on Inflammatory Bowel Disease (IBD) medical research, public health and therapy development issues; FY 2022 budget reconciliation.
S. 464, H.R. 2163 - the Safe Step Act; Education and awareness of IBD issues including Congressional Crohns & Colitis Caucus.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · third_quarter · Q3
21st Century Cures 2.0; Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · second_quarter · Q2
Appropriations to support public health programs focused on psoriasis and psoriatic arthritis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · second_quarter · Q2
FY 2022 appropriations focused on Inflammatory Bowel Disease (IBD) medical research, public health and therapy development issues.
S. 464, H.R. 2163 - the Safe Step Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
USAGAINSTALZHEIMER'S via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · second_quarter · Q2
21st Century Cures 2.0; Advanced Research Projects Agency for Health (ARPA-H)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · first_quarter · Q1
FY 22 appropriations to support public health issues pertaining to psoriasis and psoriatic arthritis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · first_quarter · Q1
FY22 appropriations focused on Inflammatory Bowel Disease (IBD) medical research, public health and therapy development issues.
S. 464 and H.R. 2163, the Safe Step Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2021 · first_quarter · RA
Fiscal year 2022 appropriations for psoriatic disease public health activities
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · fourth_quarter · Q4
H.R. 2279, S. 2546 - Safe Step Act and issues related to step therapy. Membership in the Crohn's & Colitis Congressional Caucus.
Fiscal Year 2021 Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD, and therapy development at FDA.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · third_quarter · Q3
Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · third_quarter · Q3
Issues related to step therapy protocols; H.R. 2279, S. 2546 - Safe Step Act. Congressional Crohn's & Colitis Caucus.
Fiscal Year 2021 Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD, and therapy development at FDA; Issues pertaining to response to COVID-19 with a focus on funding for CDC and NIH.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · second_quarter · Q2
Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · second_quarter · Q2
Issues related to step therapy protocols; H.R. 2279, S.2546 - Safe Step Act
Fiscal Year 2021 Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD, and therapy development at FDA; Issues pertaining to response to COVID-19 with a focus on funding for CDC and NIH.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · first_quarter · Q1
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL PSORIASIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · first_quarter · RA
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities; Concerns regarding psoriatic disease and military service; H.R. 2279, S. 2546 - Safe Step Act
CROHN'S & COLITIS FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · first_quarter · RR
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2279 and S.2546 - Safe Step Act
GLOBAL DOWN SYNDROME FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2020 · first_quarter · RR
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding; Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding; Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome
Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding; Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome